CN Patent

CN107847499A — 治疗神经退行性疾病的方法

Assigned to Ai Wan Science Co ltd · Expires 2018-03-27 · 8y expired

What this patent protects

本申请涉及5‑HT 6 受体拮抗剂，特别是高剂量的3‑苯基磺酰基‑8‑哌嗪基‑1基‑喹啉的新用途，并且涉及5‑HT 6 受体拮抗剂，特别是3‑苯基磺酰基‑8‑哌嗪基‑1基‑喹啉与用于治疗神经退行性疾病的乙酰胆碱酯酶抑制剂的组合。

USPTO Abstract

本申请涉及5‑HT 6 受体拮抗剂，特别是高剂量的3‑苯基磺酰基‑8‑哌嗪基‑1基‑喹啉的新用途，并且涉及5‑HT 6 受体拮抗剂，特别是3‑苯基磺酰基‑8‑哌嗪基‑1基‑喹啉与用于治疗神经退行性疾病的乙酰胆碱酯酶抑制剂的组合。

Drugs covered by this patent

Patent Metadata

Patent number
CN107847499A
Jurisdiction
CN
Classification
—
Expires
2018-03-27
Drug substance claim
No
Drug product claim
No
Assignee
Ai Wan Science Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.